Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
1,170.10
-4.90 (-0.42%)
Nov 11, 2026, 1:40 PM IST

Senores Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,3351,154585.6314.584.339.91
Depreciation & Amortization
333.8272.8137.894.63.691.42
Other Amortization
39.739.730.65.614.15.63
Loss (Gain) From Sale of Assets
-1-1----
Other Operating Activities
793.7573.7131.1-11.233.193.89
Change in Accounts Receivable
-499.8-1,973-118.8-571.1-24.74-194
Change in Inventory
-326.3-303.4-192.6-10.4-1.42-26.44
Change in Accounts Payable
203.11,605-457.950964.4670.07
Change in Other Net Operating Assets
-1,208-747-575-588-184.425.05
Operating Cash Flow
670.5620.5-459.2-257-10.79-104.47
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,046-2,647-1,575-518.3-472.77-106.82
Sale of Property, Plant & Equipment
1.81.8----
Cash Acquisitions
-138.4-318.5-36.9-32.9--
Investment in Securities
356.31,619-2,758--10.49-139.52
Other Investing Activities
86.1139.971.64.70.391.94
Investing Cash Flow
-2,741-1,206-4,295-542.3-482.87-244.4

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--922580.4290.415.06
Long-Term Debt Issued
-176.8295.431.7175.4689.93
Total Debt Issued
924.5176.81,217612.1465.86104.99
Short-Term Debt Repaid
--156.8----
Long-Term Debt Repaid
----13.7--0.87
Lease Payments
7.1---13.7--0.87
Total Debt Repaid
547.1-156.8--13.7--0.87
Net Debt Issued (Repaid)
1,472201,217598.4465.86104.12
Issuance of Common Stock
236.2236.24,718369.926.82240.21
Other Financing Activities
-318.7-269.5-203.7-98.5-30.1720.29
Financing Cash Flow
1,389-13.35,731869.8462.51364.62

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
0.20.1-5--
Net Cash Flow
-680.7-598.3977.375.5-31.1515.75

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-2,376-2,027-2,034-775.3-483.56-211.29
Free Cash Flow Growth
------
Free Cash Flow Margin
-33.06%-32.04%-51.08%-36.14%-136.84%-149.11%
Free Cash Flow Per Share
-51.92-44.01-55.94-30.09-38.12-38.53
Levered Free Cash Flow
-3,526-2,890-2,414-1,035-543.86-
Unlevered Free Cash Flow
-3,347-2,741-2,287-982-532.38-
Free Cash Flow After Leases
-2,369-2,027-2,034-789-483.56-212.16

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
297.3250.3203.68518.375.1
Cash Income Tax Paid
15313291.724.914.531.41
Change in Working Capital
-1,831-1,419-1,344-660.5-146.1-125.32